key: cord-0866486-403nyomq
authors: Dolinay, Tamas; Jun, Dale; Chen, Lucia; Gornbein, Jeffrey
title: Mechanical ventilator liberation of COVID-19 patients in long-term acute care facility
date: 2022-02-25
journal: Chest
DOI: 10.1016/j.chest.2022.02.030
sha: a60f29c6a30fc4cb2abc2ba8aa627a73bc79681f
doc_id: 866486
cord_uid: 403nyomq

Background Mechanical ventilation via tracheostomy is commonly performed for patients post respiratory failure in long-term acute care hospitals (LTACHs). However the outcome of mechanical ventilation in COVID-19-associated respiratory failure in the LTACH is not known. Research question What is the ventilator liberation rate of tracheostomized patients with COVID-19-associated respiratory failure (COVID) compared to respiratory failure unrelated to COVID-19 (non-COVID) in the LTACH? Study Design and Methods In this retrospective cohort study, we examined mechanically ventilated patients discharged between June 2020 and March 2021. Of 242 discharges, 165 patients arrived with tracheostomy and were considered for ventilator liberation. N=128 patients were non-COVID and N=37 patients were admitted for COVID. Results The primary outcome of the study was ventilator liberation; secondary outcomes were: functional recovery, length of stay (LOS) at LTACH and discharge disposition. After controlling for demographics, the number of comorbidities, hemodialysis, vasopressor need, thrombocytopenia and the LOS at the STACH, our results indicate that COVID patients had a higher adjusted ventilator liberation rate of 91.4% versus 56.0% in their non-COVID peers. Functional ability was assessed with the change of Functional Status Score for the Intensive Care Unit (FSS-ICU) score between admission and discharge. The adjusted mean change in FSS-ICU score was significantly higher in the COVID group than in the non-COVID group 9.49 (95% CI=7.38-11.6) versus 2.08 (95% CI =1.05-3.11) in the non-COVID group (p<0.001). COVID patients had a shorter adjusted LOS at the LTACH with an adjusted hazard ratio (HR)=1.57 (95% CI=1.0-2.46, p=0.05) compared to non-COVID. We did not observe significant differences between the two groups in their discharge location, but there was a trend towards need for lower level of care in COVID patients. Interpretation Our study suggests that COVID patients requiring mechanical ventilation and tracheostomy have a higher chance for recovery than their non-COVID counterparts.

Results: The primary outcome of the study was ventilator liberation; secondary outcomes were: functional recovery, length of stay (LOS) at LTACH and discharge disposition. After controlling for demographics, the number of comorbidities, hemodialysis, vasopressor need, thrombocytopenia and the LOS at the STACH, our results indicate that COVID patients had a higher adjusted ventilator liberation rate of 91.4% versus 56.0% in their non-COVID peers.

Functional ability was assessed with the change of Functional Status Score for the Intensive Care Unit (FSS-ICU) score between admission and discharge. The adjusted mean change in FSS-ICU score was significantly higher in the COVID group than in the non-COVID group 9.49 (95% CI=7.38-11.6) versus 2.08 (95% CI =1.05-3.11) in the non-COVID group (p<0.001). COVID patients had a shorter adjusted LOS at the LTACH with an adjusted hazard ratio (HR)=1.57 (95% CI=1.0-2.46, p=0.05) compared to non-COVID. We did not observe significant differences between the two groups in their discharge location, but there was a trend towards need for lower level of care in COVID patients.

Interpretation: Our study suggests that COVID patients requiring mechanical ventilation and tracheostomy have a higher chance for recovery than their non-COVID counterparts.

The COVID-19 pandemic resulted in an unforeseen stress on health care systems. By January, 2022 the USA alone had 2.76 million COVID 19-related hospitalizations 1 . It is estimated that 10% of all hospitalized patients with COVID-19 develop severe acute respiratory failure requiring invasive mechanical ventilation (MV) 2 . Studies show that 8-13% of patients admitted to intensive care units will receive tracheostomy to allow MV for extended periods of J o u r n a l P r e -p r o o f 6 time 3 .Tracheostomies are usually placed after 1-3 weeks of unsuccessful liberation from MV to facilitate longer-term recovery 4 . They are well tolerated and improve ventilator outcomes 5,6 , but it is unknown what is the overall recovery potential of MV patients COVID-19 associated respiratory failure.

In the USA, following tracheostomy, medically stable patients who have a potential for liberation from mechanical ventilation are often transferred to LTACHs for continued care.

LTACHs are often called "weaning facilities" but they also provide rehabilitation for chronically critically ill (CCI) patients. Despite significant efforts by LTACHs, a multicenter analysis by Scheinhorn et al. suggest that only about 54% of patients admitted for ventilator liberation are successfully liberated 7 .

Our hypothesis was that patients admitted with COVID-19 respiratory failure (COVID) to the LTACH have better chance for ventilator liberation and recovery than patients admitted for non-COVID-19 associated respiratory failure (non-COVID). To test our hypothesis, we studied 165 patients who were discharged during the 2020-2021 COVID-19 epidemic. In this retrospective cohort study, we analyze the potential reasons for ventilator liberation success in this severely ill population.

Barlow Respiratory Hospital (BRH) is a 105-bed non-profit LTACH in the Los Angeles area. BRH follows Centers for Medicare and Medicaid Services (CMS) guidelines 8 for admission (e- Table 1 ). BRH sees a generally sicker patient population (marked by a higher case mix index 9 ) with a higher numbers of patients admitted for ventilator liberation and a higher number of admission denials than national average (e- Table 2 ) based on data from the LTACH outcomes system (LTRAX) 10 .

The study was approved by Western Institutional Review Board #1-1348082-1. To study the outcomes of mechanical ventilation at BRH during the 2020-2021 COVID-19 pandemic, we focused 242 consecutive discharges between June 1, 2020 and March 5, 2021. Study inclusion and exclusion criteria are listed in the online supplement. In brief, there was no difference in the admission criteria between non-COVID and COVID patients. Patients with respiratory failure unrelated to COVID-19 (non-COVID) were compared to patients with COVID-19-associated respiratory failure (COVID). Of the 242 patients, we excluded those who did not participate in our ventilator liberation program or presented with an oropharyngeal intubation tube on admission. The decision to exclude these patients from the ventilator liberation program was made by the admitting team and included: 1. unresponsiveness (Glasgow Coma Scale<6), 2. hemodynamic instability, 3. severe muscle weakness, 4. readmission with failed prior attempt of ventilator liberation, 5. <24 hours stay at BRH. Patients with oropharyngeal tube intubation were excluded because tracheostomy change their hospitalization time at BRH. Excluded patients are shown in e- Table 3 . Patients who participated in the ventilator liberation program, received comprehensive respiratory, medical, physical, occupational and speech therapy. Data was extracted from electronic medical records and stored in protected database.

J o u r n a l P r e -p r o o f On admission, volume control, pressure control and hybrid modes (e.g. synchronized intermittent mandatory ventilation mode) were considered full support MV and pressure support mode was considered spontaneous ventilator mode MV. Ventilator liberation was defined as cessation of MV for at least 48 hours prior to discharge. Ventilator dependence was defined as continued MV on discharge 11 .

To adequately compare non-COVID and COVID patients, we developed statistical models to correct for nine potential confounders (covariates) that have been described as modifiers of mechanical ventilation outcomes: 1. age 12 , 2. gender 13 , 3. race/ethnicity 13 , 4. need for vasopressor 14 at the short-term acute care hospital (STACH), 5. thrombocytopenia (platelet count<150x10 3 /µL) 15 on LTACH admission, 6. need for hemodialysis 16 at LTACH, 7. length of stay 17 at STACH, 8. the number of acute and 9. chronic comorbidities 16 (Table 1 and e-Table 4 ).

Comorbidities present prior to LTACH admission were reviewed from available medical records and we generated a list of acute and chronic medical conditions that were considered for covariate adjustment. Acute comorbidities included: acute respiratory distress syndrome (ARDS), sepsis, acute kidney injury (AKI), acute venous thromboembolism (VTE) including deep venous thrombosis (DVT) and pulmonary embolism (PE). Chronic stable comorbidities documented at the at the referring STACH included: hypertension, diabetes mellitus, congestive heart failure (CHF), prior cerebrovascular accident (CVA), coronary artery disease (CAD), obesity with body mass index (BMI) greater than 30 and pulmonary fibrosis. The number of acute comorbidities of each patient were aggregated in a single number and the number of chronic comorbidities were aggregated into a different number. Both were used as a covariate (Table 1) . Definition for comorbidities is shown in the online supplement. transferring from lying to sitting, c) sitting at the edge of bed, d) transfer from sit to stand, and d)

walking. Each task is scored on a 0 (no function) to 7 (independent performance) scale. The minimum combined score is 0 and the maximum is 35. The FSS-ICU score has been validated in both the ICU 19 and the LTACH 20 settings. Patients were evaluated by a physical therapist on admission and discharge, and the change in FSS-ICU score was used to access for functional change.

We created five ordered discharge categories to show patient disposition. Discharges were ordered to represent more independent living as a better outcome: 1=home: great, 2= inpatient rehabilitation facility (IPR): good, 3= skilled nursing facility (SNF): standard, 4=STACH transfer: poor, 5=death: very poor.

Univariate analysis. Categorical variables between non-COVID and COVID groups were compared using chi-square and Fisher's exact tests. Continuous variables for demographics and outcomes were compared with t-tests, non-parametric Wilcoxon rank sum test or log-rank tests as appropriate (Table 1) (Table 2 and e-Table 5 ). 2.

The change in FSS-ICU score between groups was assessed using linear regression (Figure 1 and e- Table 6 ). Admission FSS-ICU score was used as an additional covariate in this analysis in the adjusted model. Unadjusted and adjusted means and mean differences are reported. 3. Length of stay (LOS) was assessed using Fine-Gray competing risk model with death as competing risk ( Figure 2 and e- Table 7 ). Unadjusted and adjusted hazard ratios (HR) and their 95% confidence interval (CI) is reported and time to event curves are shown (Figure 1 ). 4. Discharge disposition was assessed using an ordinal logistic model because the five discharge disposition categories were ordered (Table 3 and e-Table 8 ). Model based odds ratios (OR) and their 95% CI along with the corresponding unadjusted and model adjusted proportions in each category are reported.

Statistical calculations were performed using Rv4.1.0 21 . We worked with a complete database without missing values. Two-tailed p-values were used, and p<0.05 was considered statistically significant.

Of 165 patients, 128 were admitted with non-COVID and 37 (22.4%) with COVID for ventilator liberation. Patient demographics is shown in Table 1 and in e- with full support, p=0.34, e- Table 4 ).

We first compared the percentage of comorbidities between non-COVID and COVID patients (Table 1) . Of comorbid conditions the presence of ARDS (27% vs. 3.9%, p<0.001) and acute kidney injury (51.4% vs 20.3%, p<0.001) on admission was more common in the COVID group than in the non-COVID group. Other comorbidities, did not significantly differ between groups. However the number of acute comorbidities was higher in the COVID group than in the non-COVID group 1.1 (SD=0.7) vs 0.5 (SD=1), p<0.001. Patients in the COVID group spent significantly longer time in the STACH than non-COVID patients prior to LTACH transfer. 

Admission FSS-ICU scores were low and not significantly different between non-COVID and COVID patients (mean=2.7 SD=3.1 vs =1.9 SD=1.7, p=0.135, e- Table 4 ). Low FSS-ICU scores signify a severely disabled population on admission. To evaluate for functional recovery we compared mean changes between admission and discharge for the two groups (Figure 1) .

Unadjusted changes are shown in Figure 2A : 2.18 (95%CI=1.14-3.22) in the non-COVID group vs. 8.93 (95% CI=7.0-10.88) in the COVID group (p<0.001). Adjusted changes are depicted in Figure 2B : 2.08 (95% CI=1.05-3.11) in the non-COVID group and 9.49 (95% CI=7.38-11.6) in J o u r n a l P r e -p r o o f the COVID group (p<0.001). The adjusted mean difference in the mean change was 7.41 (95% CI=4.94-9.87, p<0.001). These results suggest that patients with COVID were able to achieve higher level of functional recovery during LTACH stay.

The median LOS to discharge from LTACH was longer for non-COVID patients compared to COVID patients with unadjusted median 50 days (interquartile range (IQR)=30-99) vs. 40 days (IQR=31-65) and adjusted median 52 days (IQR=31-97) vs. 39 days (28-63), respectively (e- Table 7 ). Figure 2A shows the cumulative incidence curves for the unadjusted probability of discharge in relation to LOS and Figure 2B shows the curves after adjustment for covariates. The unadjusted HR for LOS in COVID versus non-COVID group was 1.29 (95% CI0.87-1.9, p=0.2) and the corresponding adjusted HR=1.57 (95% CI=1.00-2.46, p=0.05). These results indicate that discharge was significantly faster in COVID group.

To further evaluate outcomes we compared the discharge disposition between the two groups. The unadjusted OR for discharge to a more independent living for non-COVID vs COVID patients was 0.43 (95% CI= 0.22-0.86, p=0.017, and after adjustment for co-variates OR=0.43 (95% CI=0.19-1.0, p=0.054). OR and p-values are listed from the statistical model in e- Table 8 . Table 3 shows the unadjusted and adjusted proportions in each of the five discharge categories. Though we did not observe statistically significant differences between the two groups in any of any discharge category after adjustment for covariates, our results suggest that COVID patients likely needed for lower level of care post discharge than their non-COVID counterparts. The current focus in COVID-19 response is the acute hospital system. Little is known what happens to those who survived the acute phase of the disease with CCI. To our knowledge, our study is the first to report outcomes of COVID-19 patients requiring MV beyond acute care hospitalization. We believe studying this population is of critical importance because they represent a significant burden on the health care system. Their rehabilitation success may also

provide an examples of how to care for the growing number of patients with CCI.

In our study, we describe a severely disabled patient population signified by their low admission FSS-ICU score. ARDS and AKI were more common in the COVID-group which is consistent with findings of Piroth and colleagues 2 . After adjustments for covariates, COVID patients showed increased rate of ventilator liberation, better physical recovery and shorter LTACH LOS. Our most important finding is that 83.8% (91.4% after adjustment for covariates) COVID patients were liberated from mechanical ventilation, which is significantly higher than the usual liberation rate at the LTACH 7,11 . Although there was no significant difference in overall discharge disposition, there was a trend toward COVID patients requiring lower level of care than their non-COVID peers. In hospital mortality remained low in both groups.

Based on our results, we speculate that the higher rate ventilator liberation success of COVID is related to their better recovery potential. A. COVID patients spent longer time at the STACH and may have already started to recover at the time of LTACH admission. B. They had significantly higher number of acute comorbidities prior to LTACH admission than non-COVID patients, but shock (measured by vasopressor use), thrombocytopenia, hemodialysis and was not different between the groups. As acute illnesses improved, COVID patient may have recovered faster. This maybe particularly important in the case of patients requiring hemodialysis because prolonged hemodialysis need is associated with poor hospital outcomes 29 . We believe that COVID patients represent a unique population in the post-acute care settings. Allowing time for rehabilitation and ventilator liberation attempts can help them to achieve a recovery beyond what is seen in the general LTACH population.

Interestingly, despite the better recovery potential of COVID patients, there was no significant difference in the discharge disposition of patients. We believe our results are confounded by the difficulty of taking care of patients with multiple medical needs. Many patients require long-term tracheostomies and continued oxygen supply, which is difficult to arrange at home, even if the patient is otherwise independent. Acute inpatient rehabilitation facilities have limited capability of taking care of patients with feeding tubes, decubitus ulcers and hemodialysis, which may necessitate lower level of care at a skilled nursing facility.

Furthermore in the USA, medical insurance status is often a determinant of placement to skilled nursing facilities even with relatively good performance status.

Our study has several strengths. First, it provides new insight to the recovery of COVID patients. Second, it confirms previous findings that patients with prolonged mechanical ventilation represent a heterogeneous group with various level of recovery potential. Third, it emphasizes the importance of rehabilitation assessment and complex rehabilitation in the LTACH setting.

Our study also has several limitations. First, patient selection may have resulted in the elimination of potential candidates for ventilator liberation. In our retrospective cohort study we enrolled small group of severely disabled, tracheostomized and ventilated patients at a single institution in Los Angeles. The patients' enrollment in the ventilator liberation program was decided by the admitting team of specialists based on medical history and physical exam (e- Table 3 ). BRH specializes in mechanically ventilated patients with higher than national ventilator liberation success, but also rejects more patients for admission than the national average (e- Table 1 and 2). However we tried to limit the effect of patient selection in our study by applying the same enrollment criteria to both groups and used covariates to control for J o u r n a l P r e -p r o o f potential confounders (Table 1 and e-Table 4 ). Second, while there was no difference in number of chronic comorbidities or in the initial ventilator settings on LTACH admission, our analysis does not adequately control for disease severity. It is possible that non-COVID patients had more severe underlying diseases with lesser chance of improvement. Third, delays in tracheostomy can alter the course of mechanical ventilation and contribute to prolonged hospitalization 30 . For this reason, we included in our analysis patients who arrived with a tracheostomy to the LTACH.

However we cannot exclude that the decision to perform tracheostomy and when to perform the tracheotomy at the STACH, may have been biased by COVID status. Fourth, we were unable to assess the long-term outcomes of our patients beyond LTACH care, which would provide additional insight in their recovery. Fifth, our database is limited to the admission records available to the study team. Despite adjustment for covariates, there is a possibility for unmeasured covariates, including the choice of COVID-19 specific medications, which could have influenced outcomes.

Our study provides new evidence that patients with COVID-19-associated respiratory failure requiring mechanical ventilation via tracheostomy have a better recovery potential than their non-COVID peers marked by improved ventilator liberation, better physical functioning and shorter LTACH stay. 

National Center for Health Statistics -Homepage. 2022; COVID data tracker

Long-Term Outcome after Prolonged Mechanical Ventilation. A Long-Term Acute-Care Hospital Study

Prediction of death and prolonged mechanical ventilation in acute lung injury

Estimating risk of mechanical ventilation and in-hospital mortality among adult COVID-19 patients admitted to Mass General Brigham: The VICE and DICE scores

Outcomes of prolonged mechanic ventilation: a discrimination model based on longitudinal health insurance and death certificate data

Ventilator Dependence Risk Score for the Prediction of Prolonged Mechanical Ventilation in Patients Who Survive Sepsis/Septic Shock with Respiratory Failure

The outcomes and prognostic factors of patients requiring prolonged mechanical ventilation

Functional Status Score for the ICU: An International Clinimetric Analysis of Validity, Responsiveness, and Minimal Important Difference

The clinical utility of the functional status score for the intensive care unit (FSS-ICU) at a long-term acute care hospital: a prospective cohort study

A language and environment for statistical computing

The epidemiology of mechanical ventilation use in the United States

How is mechanical ventilation employed in the intensive care unit? An international utilization review

Long-Term Outcomes and Health Care Utilization after Prolonged Mechanical Ventilation

Long-term acute care hospital utilization after critical illness

Mechanical Ventilation in COVID-19: Interpreting the Current Epidemiology

Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area

Timing of Tracheostomy for Patients With COVID-19 in the ICU-Setting Precedent in Unprecedented Times

Association of Hospitalization and Mortality Among Patients Initiating Dialysis With Hemodialysis Facility Ownership and Acquisitions. considered significantly different. Abbreviations: non-COVID=respiratory failure unrelated to COVID-19 infection, COVID= COVID-19 associated respiratory failure, ARDS=acute respiratory distress syndrome, AKI= acute kidney injury, CKD= chronic kidney disease, BMI= Body Mass Index, CVA= cerebrovascular accident, VTE=venous thromboembolism, N=number, SD= standard deviation, LOS=length of stay, STACH=short-term acute care hospital, LTACH=long=term acute care hospital

Discharges were ordered in five categories and with the more independent living as the better outcome: 1=home: great, 2=IPR: good, 3=SNF: standard, 4=STACH transfer: poor, 5=death: very poor. Unadjusted and adjusted proportions in each of the five discharge categories shown

Abbreviations: home= discharge to home, IRF= discharge to inpatient rehabilitation facility, SNF= discharge to skilled nursing facility, STACH transfer= readmission to STACH, 5. Death= inpatient death, p-values represent non-COVID vs

Tamas Dolinay takes responsibility for the content of the manuscript including the data and analysis. TD and DJ contributed to data collection, study design, data analysis and interpretation. TD, LC, JG contributed to data model development and analysis. TD, DJ, LC and